| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
National Center for Complementary and Alternative Medicine (NCCAM) |
| Information provided by: | National Center for Complementary and Alternative Medicine (NCCAM) |
| ClinicalTrials.gov Identifier: | NCT00065416 |
Purpose
This study will provide the basis for a full-scale trial to evaluate the effectiveness and safety of therapeutic massage for chronic neck pain (CNP).
| Condition | Intervention | Phase |
|
Neck Pain Cervicalgia |
Procedure: massage |
Phase I Phase II |
| MedlinePlus related topics: | Neck Injuries and Disorders |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Placebo Control, Parallel Assignment, Safety/Efficacy Study |
| Estimated Enrollment: | 60 |
Neck pain is one of the most common problems affecting the health of Americans and is a leading reason for using complementary or alternative medical (CAM) therapies. Therapeutic massage is one of the most popular CAM treatments for neck pain, but little is known about its effectiveness. This study will lay the groundwork for a full-scale trial that evaluates the effectiveness of therapeutic massage for chronic neck pain.
The study will involve two phases. During Phase I, researchers will develop and pre-test key components for a randomized clinical trial. In Phase II, the safety and efficacy of massage for CNP will be evaluated. The changes in symptoms, function, and quality of life in massage and self care groups will be evaluated midway through treatment, at the end of treatment and at 6 months post randomization.
Eligibility
| Ages Eligible for Study: | 20 Years to 64 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
The inclusion and exclusion criteria will be developed through consultation with a medical expert on neck pain and several massage consultants
Contacts and Locations| United States, Washington | |||||
| Group Health Cooperative, Center for Health Studies | |||||
| Seattle, Washington, United States | |||||
| Principal Investigator: | Karen J Sherman, PhD | Group Health Cooperative Center for Health Studies |
More Information
| Study ID Numbers: | R21 AT001584-01 |
| First Received: | July 22, 2003 |
| Last Updated: | June 23, 2005 |
| ClinicalTrials.gov Identifier: | NCT00065416 |
| Health Authority: | United States: Federal Government |
|
|
|
|
